ALFA Finder
10:51 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Natco Pharma Ltd
Natco Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹808.95
- Market cap
- ₹15,869 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.9×Sector 43.8×
- Promoter holding
- 46.22%-3.20% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Capital Structure Change 5Board Meeting Date 5Other Announcement 4Fund Raise 3Financial Results 3Board Meeting Outcome 3Annual General Meeting 3Acquisition 3Share Pledge 2Regulatory Approval 2Legal & Regulatory 2Promoter Selling (Off-Market) 1Product Launch 1Merger & Restructuring 1Management Change 1Employee Stock Options 1Dividend 1Business Update 1Annual Report 1
Time
4 announcements with these filters
16:55 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.
20:32 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26.
11:41 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Limited submitted its compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The registrar confirmed that securities received for dematerialization were processed and the depositories' records updated within 15 days.